These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32321407)

  • 1. Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVM
    Serseg T; Benarous K; Yousfi M
    Curr Comput Aided Drug Des; 2021; 17(3):469-479. PubMed ID: 32321407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL
    Liu WS; Li HG; Ding CH; Zhang HX; Wang RR; Li JQ
    Aging (Albany NY); 2021 Mar; 13(5):6258-6272. PubMed ID: 33678621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease.
    Basu S; Veeraraghavan B; Ramaiah S; Anbarasu A
    Microb Pathog; 2020 Dec; 149():104546. PubMed ID: 33011363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro.
    Zhang L; Liu J; Cao R; Xu M; Wu Y; Shang W; Wang X; Zhang H; Jiang X; Sun Y; Hu H; Li Y; Zou G; Zhang M; Zhao L; Li W; Guo X; Zhuang X; Yang XL; Shi ZL; Deng F; Hu Z; Xiao G; Wang M; Zhong W
    Virol Sin; 2020 Dec; 35(6):776-784. PubMed ID: 32910347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Chiou WC; Chen JC; Chen YT; Yang JM; Hwang LH; Lyu YS; Yang HY; Huang C
    Biochem Biophys Res Commun; 2022 Feb; 591():130-136. PubMed ID: 33454058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the antiviral therapeutic potentialities of marine polycyclic lamellarin pyrrole alkaloids as promising inhibitors for SARS-CoV-2 and Zika main proteases (Mpro).
    Pereira F; Bedda L; Tammam MA; Alabdullah AK; Arafa R; El-Demerdash A
    J Biomol Struct Dyn; 2024 May; 42(8):3983-4001. PubMed ID: 37232419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease.
    Gahlawat A; Kumar N; Kumar R; Sandhu H; Singh IP; Singh S; Sjöstedt A; Garg P
    J Chem Inf Model; 2020 Dec; 60(12):5781-5793. PubMed ID: 32687345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
    El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM
    Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.
    Deeks HM; Walters RK; Barnoud J; Glowacki DR; Mulholland AJ
    J Chem Inf Model; 2020 Dec; 60(12):5803-5814. PubMed ID: 33174415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of New Hydroxyethylamine Analogs against 3CL
    Kumar S; Sharma PP; Shankar U; Kumar D; Joshi SK; Pena L; Durvasula R; Kumar A; Kempaiah P; Poonam ; Rathi B
    J Chem Inf Model; 2020 Dec; 60(12):5754-5770. PubMed ID: 32551639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL
    Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
    Ghosh A; Chakraborty M; Chandra A; Alam MP
    J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations.
    Shaji D; Yamamoto S; Saito R; Suzuki R; Nakamura S; Kurita N
    Biophys Chem; 2021 Aug; 275():106608. PubMed ID: 33962341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based in silico design of SARS-CoV-2 main protease inhibitors.
    Ahmad S; Usman Mirza M; Yean Kee L; Nazir M; Abdul Rahman N; Trant JF; Abdullah I
    Chem Biol Drug Des; 2021 Oct; 98(4):604-619. PubMed ID: 34148292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay.
    Loschwitz J; Jäckering A; Keutmann M; Olagunju M; Eberle RJ; Coronado MA; Olubiyi OO; Strodel B
    Bioorg Chem; 2021 Jun; 111():104862. PubMed ID: 33862474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica molecular dynamics simulations.
    Liang S; Liu X; Zhang S; Li M; Zhang Q; Chen J
    Phys Chem Chem Phys; 2022 Jan; 24(3):1743-1759. PubMed ID: 34985081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL
    Cesar Ramos de Jesus H; Solis N; Machado Y; Pablos I; Bell PA; Kappelhoff R; Grin PM; Sorgi CA; Butler GS; Overall CM
    J Virol; 2024 Jun; 98(6):e0004924. PubMed ID: 38742901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.